Daratumumab in T-cell acute lymphoblastic leukaemia: A case report and review of the literature

Pediatr Blood Cancer. 2021 May;68(5):e28829. doi: 10.1002/pbc.28829. Epub 2020 Nov 27.
No abstract available

Publication types

  • Case Reports
  • Letter
  • Review

MeSH terms

  • Antibodies, Monoclonal / therapeutic use*
  • Antineoplastic Agents / therapeutic use*
  • Child, Preschool
  • Humans
  • Male
  • Precursor T-Cell Lymphoblastic Leukemia-Lymphoma / drug therapy*

Substances

  • Antibodies, Monoclonal
  • Antineoplastic Agents
  • daratumumab

Associated data

  • ClinicalTrials.gov/NCT03384654